1. Home
  2. Analysis
  3. Erythromycin
  4. Trasylol

Erythromycin and Trasylol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erythromycin (erythromycin) and Trasylol (aprotinin). Common drug interactions include anxiety among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Erythromycin and Trasylol. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.

What is Trasylol?

Trasylol has active ingredients of aprotinin. eHealthMe is studying from 9,460 Trasylol users. Check the latest studies of Trasylol.

On Jul, 12, 2026

16 people who take Erythromycin and Trasylol together, and have interactions are studied.

Erythromycin and Trasylol drug interactions.

What are the common drug interactions of Erythromycin and Trasylol, by gender? *:

female:

  1. Anxiety
  2. Emotional distress
  3. Fear
  4. Injury
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Renal injury (kidney injury)
  9. Stress
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Pain
  2. Injury
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Death
  5. Depression
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Nervousness
  9. Renal failure acute (rapid kidney dysfunction)
  10. Anaemia (lack of blood)

What are the common drug interactions of Erythromycin and Trasylol, by age (0-1 to 60+)? *:

0-1:

  1. Death
  2. Injury
  3. Pain
  4. Renal failure (kidney dysfunction)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Renal injury (kidney injury)

2-9:

n/a

10-19:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Death
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Depression
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Nervousness
  9. Pain
  10. Renal failure (kidney dysfunction)

30-39:

  1. Anxiety
  2. Emotional distress
  3. Fear
  4. Injury
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Renal injury (kidney injury)
  9. Stress

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Fear
  5. Injury
  6. Pain
  7. Renal failure (kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)
  9. Renal injury (kidney injury)
  10. Stress

50-59:

  1. Anxiety
  2. Emotional distress
  3. Fear
  4. Injury
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Renal impairment (severely reduced kidney function)
  8. Renal injury (kidney injury)
  9. Stress
  10. Anaemia (lack of blood)

60+:

  1. Pain
  2. Injury
  3. Stress
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Multi-organ failure (multisystem organ failure)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Death
  9. Emotional disorder
  10. Haemorrhagic anaemia (anaemia due to excessive bleeding)

What are the existing conditions these people have? *

  1. Retinopathy Proliferative (a condition in which very small blood vessels grow from the surface of the retina and damages retina): 1 person, 6.25%
  2. Renal Impairment (severely reduced kidney function): 1 person, 6.25%
  3. Postoperative Wound Infection: 1 person, 6.25%
  4. Pain: 1 person, 6.25%
  5. Atrial Thrombosis (blood clot that develops in an artery): 1 person, 6.25%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Erythromycin and Trasylol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Erythromycin and Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trasylol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin and aprotinin (the active ingredients of Erythromycin and Trasylol, respectively), and Erythromycin and Trasylol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.